Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study
Background: to evaluate the residual rate and the functional results after ten years from canal wall down tympanoplasty (CWD) for tympano-mastoid cholesteatoma. Methods: All the patients undergoing CWD for chronic otitis media with cholesteatoma at our ENT University Department between January 2002...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/11/1745 |
_version_ | 1797467596618989568 |
---|---|
author | Salvatore Ferlito Ignazio La Mantia Federico Merlino Salvatore Cocuzza Arianna Di Stadio Giovanni Cammaroto Ricardo Bartel Gianluca Fadda Giannicola Iannella Quentin Mat Stéphane Gargula Justin Michel Nicolas Fakhry Antonino Maniaci |
author_facet | Salvatore Ferlito Ignazio La Mantia Federico Merlino Salvatore Cocuzza Arianna Di Stadio Giovanni Cammaroto Ricardo Bartel Gianluca Fadda Giannicola Iannella Quentin Mat Stéphane Gargula Justin Michel Nicolas Fakhry Antonino Maniaci |
author_sort | Salvatore Ferlito |
collection | DOAJ |
description | Background: to evaluate the residual rate and the functional results after ten years from canal wall down tympanoplasty (CWD) for tympano-mastoid cholesteatoma. Methods: All the patients undergoing CWD for chronic otitis media with cholesteatoma at our ENT University Department between January 2002 and December 2022 were initially assessed. We performed clinical and diagnostic evaluation at baseline, 6 months, and then every year until an average follow-up of 10 years was obtained. Patients were consequently divided into two groups according to the presence (group A) or absence (group B) of the stapes superstructure. Results: After the selection process, 176 ears were included. The presence of the stapes superstructure was associated with better hearing outcomes (rate of patients < 30 dB) at 6 months (91.42% vs. 74.46%; <i>p</i> = 0.001) and 10 years (74.46% vs. 24.11%; <i>p</i> < 0.001). Residual cholesteatoma was reported in 10 ears, which included 2/35 ears in group A (5.71 %) and 8/141 in group B (5.67 %) (<i>p</i> = 0.993). The recurrent cholesteatoma rate was respectively 1/35 (2.85%) vs. 3/141 (2.18%) (<i>p</i> = 0.516). Conclusions: the CWD approach to cholesteatoma allows for effective long-term anatomical disease control and good hearing results when the stapes superstructure is preserved. |
first_indexed | 2024-03-09T18:55:55Z |
format | Article |
id | doaj.art-959b9eee6dbf4e8cb7d88598ccf6cee5 |
institution | Directory Open Access Journal |
issn | 2075-1729 |
language | English |
last_indexed | 2024-03-09T18:55:55Z |
publishDate | 2022-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Life |
spelling | doaj.art-959b9eee6dbf4e8cb7d88598ccf6cee52023-11-24T05:30:16ZengMDPI AGLife2075-17292022-10-011211174510.3390/life12111745Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective StudySalvatore Ferlito0Ignazio La Mantia1Federico Merlino2Salvatore Cocuzza3Arianna Di Stadio4Giovanni Cammaroto5Ricardo Bartel6Gianluca Fadda7Giannicola Iannella8Quentin Mat9Stéphane Gargula10Justin Michel11Nicolas Fakhry12Antonino Maniaci13Department of Medical and Surgical Sciences and Advanced Technologies “GF Ingrassia” ENT Section, University of Catania, 95123 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “GF Ingrassia” ENT Section, University of Catania, 95123 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “GF Ingrassia” ENT Section, University of Catania, 95123 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “GF Ingrassia” ENT Section, University of Catania, 95123 Catania, ItalyDepartment of Medical and Surgical Sciences and Advanced Technologies “GF Ingrassia” ENT Section, University of Catania, 95123 Catania, ItalyDepartment of Otolaryngology-Head and Neck Surgery, Morgagni Pierantoni Hospital, 47121 Forli, ItalyDepartment of Otorhinolaryngology and Head and Neck Surgery, Hospital Universitario Mutua Terrasa, 08221 Barcelona, SpainDepartment of Otorhinolaryngology, San Luigi Gonzaga University Hospital, Università degli Studi di Torino, 10137 Turin, ItalyDepartment of Sensory Organs, “Sapienza” University of Rome, 00100 Rome, ItalyDepartment of Otorhinolaryngology, C.H.U. Charleroi, 6000 Charleroi, BelgiumDepartment of Otorhinolaryngology, Lariboisière Hospital, Assistance Publique–Hôpitaux de Paris, 75610 Paris, FranceService D’otorhinolaryngologie et de Chirurgie Cervico-Faciale, Université Aix-Marseille, Hôpital de La Conception, 147, Boulevard Baille, 13005 Marseille, FranceService D’otorhinolaryngologie et de Chirurgie Cervico-Faciale, Université Aix-Marseille, Hôpital de La Conception, 147, Boulevard Baille, 13005 Marseille, FranceDepartment of Medical and Surgical Sciences and Advanced Technologies “GF Ingrassia” ENT Section, University of Catania, 95123 Catania, ItalyBackground: to evaluate the residual rate and the functional results after ten years from canal wall down tympanoplasty (CWD) for tympano-mastoid cholesteatoma. Methods: All the patients undergoing CWD for chronic otitis media with cholesteatoma at our ENT University Department between January 2002 and December 2022 were initially assessed. We performed clinical and diagnostic evaluation at baseline, 6 months, and then every year until an average follow-up of 10 years was obtained. Patients were consequently divided into two groups according to the presence (group A) or absence (group B) of the stapes superstructure. Results: After the selection process, 176 ears were included. The presence of the stapes superstructure was associated with better hearing outcomes (rate of patients < 30 dB) at 6 months (91.42% vs. 74.46%; <i>p</i> = 0.001) and 10 years (74.46% vs. 24.11%; <i>p</i> < 0.001). Residual cholesteatoma was reported in 10 ears, which included 2/35 ears in group A (5.71 %) and 8/141 in group B (5.67 %) (<i>p</i> = 0.993). The recurrent cholesteatoma rate was respectively 1/35 (2.85%) vs. 3/141 (2.18%) (<i>p</i> = 0.516). Conclusions: the CWD approach to cholesteatoma allows for effective long-term anatomical disease control and good hearing results when the stapes superstructure is preserved.https://www.mdpi.com/2075-1729/12/11/1745tympanomastoid cholesteatomacanal wall down mastoidectomyresidual diseaserecurrence rate |
spellingShingle | Salvatore Ferlito Ignazio La Mantia Federico Merlino Salvatore Cocuzza Arianna Di Stadio Giovanni Cammaroto Ricardo Bartel Gianluca Fadda Giannicola Iannella Quentin Mat Stéphane Gargula Justin Michel Nicolas Fakhry Antonino Maniaci Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study Life tympanomastoid cholesteatoma canal wall down mastoidectomy residual disease recurrence rate |
title | Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study |
title_full | Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study |
title_fullStr | Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study |
title_full_unstemmed | Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study |
title_short | Long-Term Anatomical and Hearing Outcomes of Canal Wall down Tympanoplasty for Tympano-Mastoid Cholesteatoma: A 20-Year Retrospective Study |
title_sort | long term anatomical and hearing outcomes of canal wall down tympanoplasty for tympano mastoid cholesteatoma a 20 year retrospective study |
topic | tympanomastoid cholesteatoma canal wall down mastoidectomy residual disease recurrence rate |
url | https://www.mdpi.com/2075-1729/12/11/1745 |
work_keys_str_mv | AT salvatoreferlito longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT ignaziolamantia longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT federicomerlino longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT salvatorecocuzza longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT ariannadistadio longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT giovannicammaroto longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT ricardobartel longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT gianlucafadda longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT giannicolaiannella longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT quentinmat longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT stephanegargula longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT justinmichel longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT nicolasfakhry longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy AT antoninomaniaci longtermanatomicalandhearingoutcomesofcanalwalldowntympanoplastyfortympanomastoidcholesteatomaa20yearretrospectivestudy |